Based on SEC filing data. A biotech corporation based in Las Vegas, Nevada raised $3.9 million in Series A funding through a convertible note. The company is in the early development stage following this financing round.
Get notified the moment Cell Source, Inc. (CLCS) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.